Government denies pressures from U.S. negotiators over new drug pricing and FTA talks

During the second round of negotiations for a proposed Korea-U.S. free trade agreement (FTA), there was no pressure from the United States on the Korean government to give up drug pricing reform or delay its introduction to protect the interest of American drug manufacturers in the Korean market said an official from the Ministry of Health and Welfare recently.

Earlier, the health ministry m...